Cigna and Centene were among a dozen companies that appeared on the initial JPM agenda that have bowed out of the conference.
More than 8,000 healthcare professionals will descend on San Francisco starting Monday for the 43rd annual J.P. Morgan ...
It's JPM 2025 and here at Fierce Biotech we’re bringing you all the latest updates live from the life sciences event of the ...
Dupixent® is now used to treat over a million patients globally, with continued growth and expansion in multiple indications for diseases in ...
Several high-profile health systems will take the stage at JPM across Monday and Tuesday. Highlights include presentations ...
John Flavin, Portal Innovations CEO, joins 'Fast Money' to talk what we can expect to see from the J.P. Morgan Healthcare ...
Dozens of Massachusetts biotech leaders will be heading to San Francisco this upcoming week for the 2025 J.P. Morgan ...
The J.P. Morgan Healthcare Conference attracts thousands of attendees each year from the provider, insurance, digital health ...